FDA Inspection 1018967 — Delaware Institute For Reproductive Medicine, P.A
The FDA completed an inspection of Delaware Institute For Reproductive Medicine, P.A on Jun 8, 2017 in Newark, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 8, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Newark, DE (United States)